Suppr超能文献

水杨酸基聚(酸酐-酯)共聚物的合成与表征

Synthesis and Characterization of Salicylic Acid-Based Poly(Anhydride-Ester) Copolymers.

作者信息

Schmeltzer Robert C, Uhrich Kathryn E

机构信息

Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854-8087, USA.

出版信息

J Bioact Compat Polym. 2006 Mar;21(2):123-133. doi: 10.1177/0883911506062976.

Abstract

A series of poly(anhydride-esters) based on poly(1,10-bis(-car-boxyphenoxy)decanoate) (CPD) and poly(1,6-bis(-carboxyphenoxy)hexane) (-CPH) were synthesized by melt-condensation polymerization. Poly-(anhydride-esters) that contain CPD hydrolytically degraded into salicylic acid, however, these homopolymers have mechanical and thermal characteristics that limit their use in clinical applications. The synthesis and characterization of copolymers of CPD with -CPH, a monomer known to generate mechanically stable homopolymers, was investigated. By changing the CPD to -CPH monomer ratios, the salicylic acid loading and thermal/mechanical properties of the copolymers was a controlling factor; increasing the CPD concentration increased the salicylate loading but decreased the polymer stability; whereas increasing the -CPH concentration increased the thermal and mechanical stability of the copolymers. Specifically, decreasing the CPD:-CPH ratio resulted in lower salicylate loading and increased thermal decomposition temperatures. The glass transition temperatures (°C) varied from 27 to 38°C, a desirable range for elastomeric biomedical implants.

摘要

通过熔融缩聚法合成了一系列基于聚(1,10 - 双(- 羧基苯氧基)癸酸酯)(CPD)和聚(1,6 - 双(- 羧基苯氧基)己烷)(-CPH)的聚(酸酐 - 酯)。含有CPD的聚(酸酐 - 酯)水解降解为水杨酸,然而,这些均聚物的机械和热性能限制了它们在临床应用中的使用。研究了CPD与 -CPH(一种已知能生成机械稳定均聚物的单体)的共聚物的合成与表征。通过改变CPD与 -CPH的单体比例,共聚物的水杨酸负载量以及热/机械性能是一个控制因素;增加CPD浓度会增加水杨酸盐负载量,但会降低聚合物稳定性;而增加 -CPH浓度会提高共聚物的热稳定性和机械稳定性。具体而言,降低CPD:-CPH比例会导致较低的水杨酸盐负载量并提高热分解温度。玻璃化转变温度(°C)在27至38°C之间变化,这对于弹性体生物医学植入物来说是一个理想的范围。

相似文献

1
Synthesis and Characterization of Salicylic Acid-Based Poly(Anhydride-Ester) Copolymers.
J Bioact Compat Polym. 2006 Mar;21(2):123-133. doi: 10.1177/0883911506062976.
2
Characterization and in vitro degradation of salicylate-derived poly(anhydride-ester microspheres).
J Microencapsul. 2006 Sep;23(6):643-53. doi: 10.1080/02652040600776481.
3
Tunable drug release profiles from salicylate-based poly(anhydride-ester) matrices using small molecule admixtures.
J Bioact Compat Polym. 2012 Nov 1;27(6):540-549. doi: 10.1177/0883911512464605.
4
Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters).
Biomaterials. 2000 Oct;21(19):1941-6. doi: 10.1016/s0142-9612(00)00073-9.
5
Iodinated salicylate-based poly(anhydride-esters) as radiopaque biomaterials.
Biomacromolecules. 2008 Jun;9(6):1604-12. doi: 10.1021/bm8000759. Epub 2008 May 16.
6
Effect of Linker Structure on Salicylic Acid-Derived Poly(anhydride-esters).
Macromolecules. 2005;38(16):6895-6901. doi: 10.1021/ma048051u.
7
Design and Synthesis of Fast-Degrading Poly(anhydride-esters).
Macromol Rapid Commun. 2009 Jun 17;30(12):1021. doi: 10.1002/marc.200900029.
8
The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
Acta Biomater. 2017 Mar 1;50:417-427. doi: 10.1016/j.actbio.2017.01.005. Epub 2017 Jan 4.
10
Comparison of salicylate-based poly(anhydride-esters) formed via melt-condensation versus solution polymerization.
J Biomater Sci Polym Ed. 2008;19(10):1295-306. doi: 10.1163/156856208786052362.

引用本文的文献

2
Inhibition of BMP9 Induced Bone Formation by Salicylic-acid Polymer Capping.
MRS Adv. 2019 Dec;4(64):3505-3512. doi: 10.1557/adv.2020.61. Epub 2019 Sep 9.
3
Poly(anhydride-ester) gemcitabine: Synthesis and particle engineering of a high payload hydrolysable polymeric drug for cancer therapy.
J Control Release. 2021 Feb 10;330:1178-1190. doi: 10.1016/j.jconrel.2020.11.025. Epub 2020 Nov 17.
4
Salicylic Acid-Based Polymers for Guided Bone Regeneration Using Bone Morphogenetic Protein-2.
Tissue Eng Part A. 2015 Jul;21(13-14):2013-24. doi: 10.1089/ten.TEA.2014.0455. Epub 2015 Apr 29.
5
PolyMorphine: an innovative biodegradable polymer drug for extended pain relief.
J Control Release. 2012 Sep 28;162(3):538-44. doi: 10.1016/j.jconrel.2012.07.033. Epub 2012 Aug 3.
6
Stability of a salicylate-based poly(anhydride-ester) to electron beam and gamma radiation.
Polym Degrad Stab. 2011 Sep 1;96(9):1625-1630. doi: 10.1016/j.polymdegradstab.2011.06.005.
7
Design and Synthesis of Fast-Degrading Poly(anhydride-esters).
Macromol Rapid Commun. 2009 Jun 17;30(12):1021. doi: 10.1002/marc.200900029.

本文引用的文献

1
Optimized Synthesis of Salicylate-based Poly(anhydride-esters).
Polym Bull (Berl). 2013 Mar 1;49(6):441-448. doi: 10.1007/s00289-003-0123-6.
2
Effect of Linker Structure on Salicylic Acid-Derived Poly(anhydride-esters).
Macromolecules. 2005;38(16):6895-6901. doi: 10.1021/ma048051u.
3
Investigation into the erosion mechanism of salicylate-based poly(anhydride-esters).
J Biomed Mater Res A. 2006 Mar 1;76(3):470-9. doi: 10.1002/jbm.a.30356.
4
Fibrin sealant tissue adhesive--review and update.
J Long Term Eff Med Implants. 2005;15(3):245-70. doi: 10.1615/jlongtermeffmedimplants.v15.i3.20.
5
Cyanoacrylates for skin closure.
Dermatol Clin. 2005 Apr;23(2):193-8. doi: 10.1016/j.det.2004.09.003.
7
Role of polyanhydrides as localized drug carriers.
J Control Release. 2005 Apr 18;103(3):541-63. doi: 10.1016/j.jconrel.2004.12.021.
8
Hemorrhage control in the battlefield: role of new hemostatic agents.
Mil Med. 2005 Jan;170(1):63-9. doi: 10.7205/milmed.170.1.63.
9
Salicylic acid-derived poly(anhydride-esters) inhibit bone resorption and formation in vivo.
J Biomed Mater Res A. 2005 Mar 15;72(4):354-62. doi: 10.1002/jbm.a.30184.
10
Synthesis and cytotoxicity of salicylate-based poly(anhydride esters).
Biomacromolecules. 2005 Jan-Feb;6(1):359-67. doi: 10.1021/bm049544+.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验